Centrally acting anticholinergic drug trihexyphenidyl is highly effective in reducing nightmares associated with post‐traumatic stress disorder

Ítems similars

• PS256. New drug therapy and the effect mechanism that the central anticholinergic drug Trihexylphenidyl reduces flashback in PTSD. The second report
  per: Katsumasa, Sogo
  Publicat: (2016)
• Nightmare recurrence in patients with post-traumatic stress disorder is likely a primary feature of central sympathetic nervous activation
  per: Gupta, Madhulika A.
  Publicat: (2020)
• Nightmare Frequency, Nightmare Distress and the Efficiency of Trauma-Focused Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder
  per: Levrier, Katia, et al.
  Publicat: (2016)
• Prazosin for Trauma Nightmares and Sleep Disturbances in Combat Veterans with Post-Traumatic Stress Disorder
  per: Khazaie, Habibolah, et al.
  Publicat: (2016)
• Treatment of Post-Traumatic Stress Disorder Nightmares at a Veterans Affairs Medical Center
  per: Detweiler, Mark B., et al.
  Publicat: (2016)